KWANGDONG PHARMACEUTICAL CO.,LTD (광동제약(주))
KOSPI Stock Code: 009290 | DART Corp Code: 00103592
English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.
| English name (as registered with DART) | KWANGDONG PHARMACEUTICAL CO.,LTD |
|---|---|
| Korean legal name | 광동제약(주) |
| Alternate names | 광동제약 |
| Market | KOSPI |
| Stock Code | 009290 |
| DART Corp Code | 00103592 |
| CEO | 최성원, 박상영(각자대표) |
| Business Registration No. | 1138108888 |
| Corporate Registration No. | 1101110152134 |
| Established Date | 1963-10-16 |
| Fiscal Month | 12 |
| KSIC Industry Code | 21220 |
| Address (KO) | 경기도 과천시 과천대로7다길 52 광동 과천 타워 |
| Homepage | https://www.ekdp.com/ |
| source_url | https://dart.fss.or.kr |
| verified_at | 2026-11-01T10:15:57.572Z |
Annual Financial Summary (KRW)
Fiscal Year: 2025 | Basis: CFS (Consolidated) | Currency: KRW | Filing Source: https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20260318001573
| Account | FY2025 (Current) | FY2024 (Prior) |
|---|---|---|
| Revenue (매출액) | KRW 1,659,512,457,700 | KRW 1,640,718,849,226 |
| Operating Income (영업이익) | KRW 31,045,848,005 | KRW 30,097,355,344 |
| Net Income (당기순이익) | KRW 21,328,798,564 | KRW 41,844,893,500 |
| Total Assets (자산총계) | KRW 1,320,329,495,616 | KRW 1,170,275,148,654 |
| Total Liabilities (부채총계) | KRW 608,533,108,468 | KRW 552,007,659,862 |
| Total Equity (자본총계) | KRW 711,796,387,148 | KRW 618,267,488,792 |
Recent DART Filings (Last 90 Days, up to 20)
| Filed Date | Receipt No. | English Title | Korean Title | Filer |
|---|---|---|---|---|
2026-10-30 | 20261030801236 | Prior Notice on Disclosure of Final Earnings | 결산실적공시예고(안내공시) | 광동제약 |
2026-10-12 | 20261012000431 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 최성원 |
2026-10-02 | 20261002000619 | Report on significant holdings of stocks, etc. (General) | 주식등의대량보유상황보고서(일반) | 최성원 |
2026-08-28 | 20260828800829 | Report on Shares Change of Largest Shareholders | 최대주주등소유주식변동신고서 | 광동제약 |
2026-08-14 | 20260814002902 | Semi-annual Report (2026.06) | 반기보고서 (2026.06) | 광동제약 |
2026-08-12 | 20260812800851 | Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure) | 연결재무제표기준영업(잠정)실적(공정공시) | 광동제약 |
Source & Disclaimer
source_url: https://dart.fss.or.kr | verified_at: 2026-11-01T10:15:57.572Z
Data from Korea's Financial Supervisory Service (DART) and National Tax Service. FSS does not guarantee accuracy or completeness. Figures in KRW as filed. Not investment advice. English names are as registered with DART and may differ from the Korean legal name. Use corp_code, stock_code, or business registration number to identify a company.